Advancing New Healthcare Solutions Through Collaboration

Phase 1/2a Clinical Trial to Begin in Second Half of July

From scientists working on a potential vaccine to medically trained employees who mobilized to the front lines to help treat patients, these men and women share what most resonates for them about the unique and devastating virus, both professionally and personally.

In his latest LinkedIn article, J&J Chief Scientific Officer Paul Stoffels shares how this year’s BIO Digital conference is uniquely positioned to bring the global biotech community together to transform health for all.

Johnson & Johnson Innovation is committed to helping patients, our partners and communities around the world manage the unprecedented impact of COVID-19.